New Iridium founder and CEO, Dr. Chern-Hooi Lim, was interviewed by Dr. Paolo Braiuca, Director of Global Market Development, Thermo Fisher Scientific for his Bringing Chemistry to Life Podcast Series. Excerpt from the episode abstract: “This is a fascinating discussion about the present and future of chemistry. We discover how photocatalysis enables a new paradigm…This…
New Iridium founder and CEO, Dr. Chern-Hooi Lim, was named to C&EN’s Talented 12 Class of 2021 by the industry’s top scientific body honoring early career chemists solving formidable global problems. Read Article
New Iridium was honored by The Biomimicry Institute (https://biomimicry.org) as a finalist for its 2021 Ray of Hope Prize. This prestigious award celebrates nature-inspired solutions addressing the world’s largest environmental and sustainability challenges. New Iridium was selected as a finalist from over 300 worldwide contestants. Read Article
New Iridium has launched a new set of photocatalysts that decrease the cost and safety risks associated with Birch Reductions. These photocatalysts allow for light-driven Birch Reductions under bench-top conditions; leading to safer scale-up reactions. New Iridium has licensed this set of products with Millipore Sigma. Read Article
Hosted by Colorado Bioscience Association, Dr. Chern-Hooi Lim participated in a panel on maximizing public-private partnerships to scale innovation. Read Article
Our Co-Founder and CEO, Dr. Chern-Hooi Lim sheds light on the uptake of New Iridium’s photocatalysis technology into the pharmaceutical industry. Read Article